IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0247383
(2016-08-25)
|
등록번호 |
US-9593101
(2017-03-14)
|
우선권정보 |
CN-2013 1 0195728 (2013-05-23); CN-2013 1 0195854 (2013-05-23) |
발명자
/ 주소 |
|
출원인 / 주소 |
- SUZHOU MIRACPHARMA TECHNOLOGY CO., LTD.
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
0 |
초록
▼
Disclosed is a method for preparing avanafil (I) by using cytosine as the starting material. The preparation steps comprise: using cytosine as the raw material, and enabling the cytosine to react with side chain 3-chlorine-4-methoxybenzyl halogen, N-(2-methylpyrimidine)methanamide and S-hydroxymethy
Disclosed is a method for preparing avanafil (I) by using cytosine as the starting material. The preparation steps comprise: using cytosine as the raw material, and enabling the cytosine to react with side chain 3-chlorine-4-methoxybenzyl halogen, N-(2-methylpyrimidine)methanamide and S-hydroxymethyl pyrrolidine, to prepare the target product avanafil (I). For the preparation method, the raw material is easily obtained, and the process is simple, economical, and environmentally friendly, so the method meets the requirement of industrial boost.
대표청구항
▼
1. A method for preparing avanafil, with the chemical name (S)-4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidylmethyl)-5-pyrimidinecarboxamide (I), Wherein the said preparation method comprises the following steps: using cytosine as raw material, the cytosine a
1. A method for preparing avanafil, with the chemical name (S)-4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidylmethyl)-5-pyrimidinecarboxamide (I), Wherein the said preparation method comprises the following steps: using cytosine as raw material, the cytosine and 3-chlorine-4-methoxybenzyl halogen (III) have a substitution reaction to produce N-(3-chloro-4-methoxybenzyl)cytosine (V) which then has a condensation reaction with S-hydroxymethyl pyrrolidine (II) to produce 4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]pyrimidine (VI). After halogenation reaction, 4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]pyrimidine (VI) and side chain N-(2-methylpyrimidine)methanamide (IV) have an addition reaction to prepare avanafil (I). 2. The method for preparing avanafil according to claim 1, wherein the halogen of 3-chlorine-4-methoxybenzyl halogen (III) is chlorine, bromine or iodine. 3. The method for preparing avanafil according to claim 1, wherein the acid-binding agents for substitution reaction are potassium carbonate, potassium hydroxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, triethylamine, diisopropylamine, pyridine, or sodium hydroxide. 4. The method for preparing avanafil according to claim 1, wherein the condensation agents for the condensation reaction are N,N,-dicyclohexyl carbodiimide, carbonyl diimidazole, N,N′-diisopropyl carbodiimide, 1-hydroxy-benzotriazole, O-2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate, O-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate or benzotriazol-1-yloxytris(dimethylamino)-phosphonium hexafluorophosphate. 5. The method for preparing avanafil according to claim 1, wherein the alkali accelerators for the condensation reaction are triethylamine, pyridine, 2,6-lutidine, 4-dimethylaminopyridine, N-methylmorpholine, N-ethylmorpholine, diisopropylethylamine, 1,5-diazabicyclo[4.3.0]-non-5-ene, 1,8-diazabicyclo[5.4.0]undec-7-ene or 1,4-diazabicyclo[2.2.2]octane. 6. The method for preparing avanafil according to claim 1, wherein the temperature of the condensation reaction is 0-120° C. 7. The method for preparing avanafil according to claim 1, wherein the halogenating agents for the halogenation reaction are chlorine, liquid bromine, or iodine. 8. The method for preparing avanafil according to claim 1, wherein the catalysts for the addition reaction are palladium chloride, palladium acetate, tris(dibenzylideneacetone)dipalladium, nickel chloride, nickel acetate. 9. The method for preparing avanafil according to claim 1, wherein the cocatalysts of the addition reaction are triphenylphosphine, tri-n-butylphosphine, tri-t-butylphosphine, tricyclohexylphosphine, tri-ethoxy-phosphine, triphenylphosphine oxide, 1,1′-bis (diphenylphosphino)ferrocene, 4,5-bis-diphenylphosphine-9,9-dimethyl-oxa anthracene or Tris(2,4-di-t-butyl)phenoxy phosphazene.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.